Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 3/20 | 0.49 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.49 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 10/20 | 0.39 |
| ▸ | CD40 | P25942 | 1/20 | 0.38 |
| ▸ | CD40LG | P29965 | 1/20 | 0.38 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.33 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.33 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16389050 | 0.83 | FUT8 (0.44) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL13483285 | 0.82 | FUT8 (0.42) | PRMT1CARM1FUT8ENPP2MEN1 | |
| SCHEMBL13881078 | 0.82 | PRMT1 (0.47) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL13483284 | 0.81 | ENPP2 (0.48) | PRMT1CARM1FUT8ENPP2MEN1 | |
| SCHEMBL4166597 | 0.81 | PRMT1 (0.69) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL3697527 | 0.81 | PRMT1 (0.69) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL12965814 | 0.81 | CD40 (0.39) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL14388936 | 0.80 | PRMT1 (0.56) | PRMT1CARM1FUT8ENPP2CD40 | |
| SCHEMBL14004226 | 0.79 | CA1 (0.39) | FUT8KMT2A | |
| SCHEMBL3692856 | 0.78 | PRMT1 (0.55) | PRMT1CARM1FUT8ENPP2CD40 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| WO-2007063024-A2 | KERATIN-BINDING EFFECTOR MOLECULES CONTAINING REACTIVE DYES | BASF SE (DE) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | PRMT1 1728/4885CARM1 4397/4885FUT8 2015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.